Aptus Endosystems
Sunnyvale
About Aptus Endosystems
Aptus Endosystems is a privately held medical technology company that has developed advanced technology for the endovascular treatment of aortic aneurysm disease. Founded in 2002, Aptus Endosystems has developed a unique endograft and endovascular stapling system that provides a durable alternative to open surgical repair by separating the functions of aneurysm exclusion and endograft fixation. The innovative helical staple technology enables independent endograft fixation, and is designed to approximate suturing in an open surgical anastomosis. The result is low profile delivery with no structural compromises, allowing surgeons to treat abdominal aortic aneurysms through a minimally invasive approach while still providing the control of an open surgical repair. The Aptus Endovascular AAA Repair Systems bear the CE Marking for distribution in the European Union. These products are Investigational Use only in the United States.w
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $40.0M
- Funding stage: M&A
- Last round: Series B (Jun 2012)
- Website: aptusendo.com
- Phone: 4085309051
Industries & Categories
Health Care, Manufacturing, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/aptus-endosystems-2433717 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.